Kobak KA - Search Results

1

St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study.

Kobak KA, Taylor LV, Bystritsky A, Kohlenberg CJ, Greist JH, Tucker P, Warner G, Futterer R, Vapnik T. Kobak KA, et al. Int Clin Psychopharmacol. 2005 Nov;20(6):299-304. doi: 10.1097/00004850-200511000-00003. Int Clin Psychopharmacol. 2005. PMID: 16192837 Clinical Trial.

2

Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study.

Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ. Kobak KA, et al. J Clin Psychopharmacol. 2002 Jun;22(3):257-62. doi: 10.1097/00004714-200206000-00005. J Clin Psychopharmacol. 2002. PMID: 12006895 Clinical Trial.

3

St. John's wort in generalized anxiety disorder: three more case reports.

Kobak KA, Taylor Lv, Futterer R, Warner G. Kobak KA, et al. J Clin Psychopharmacol. 2003 Oct;23(5):531-2. doi: 10.1097/01.jcp.0000088921.02635.13. J Clin Psychopharmacol. 2003. PMID: 14520138 No abstract available.

4

St. John's wort versus placebo in social phobia: results from a placebo-controlled pilot study.

Kobak KA, Taylor LV, Warner G, Futterer R. Kobak KA, et al. J Clin Psychopharmacol. 2005 Feb;25(1):51-8. doi: 10.1097/01.jcp.0000150227.61501.00. J Clin Psychopharmacol. 2005. PMID: 15643100 Clinical Trial.

5

A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder.

Greist JH, Jefferson JW, Kobak KA, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowtiz MR, Lydiard B, et al. Greist JH, et al. Among authors: kobak ka. Int Clin Psychopharmacol. 1995 Jun;10(2):57-65. doi: 10.1097/00004850-199506000-00001. Int Clin Psychopharmacol. 1995. PMID: 7673657 Clinical Trial.

6

Behavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis.

Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ, Henk HJ. Kobak KA, et al. Psychopharmacology (Berl). 1998 Apr;136(3):205-16. doi: 10.1007/s002130050558. Psychopharmacology (Berl). 1998. PMID: 9566805

7

Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control.

Greist JH, Marks IM, Baer L, Kobak KA, Wenzel KW, Hirsch MJ, Mantle JM, Clary CM. Greist JH, et al. Among authors: kobak ka. J Clin Psychiatry. 2002 Feb;63(2):138-45. doi: 10.4088/jcp.v63n0209. J Clin Psychiatry. 2002. PMID: 11874215 Clinical Trial.

8

A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.

March JS, Kobak KA, Jefferson JW, Mazza J, Greist JH. March JS, et al. Among authors: kobak ka. J Clin Psychiatry. 1990 May;51(5):200-2. J Clin Psychiatry. 1990. PMID: 2110560 Clinical Trial.

9

Sertraline for social phobia: a double-blind, placebo-controlled crossover study.

Katzelnick DJ, Kobak KA, Greist JH, Jefferson JW, Mantle JM, Serlin RC. Katzelnick DJ, et al. Among authors: kobak ka. Am J Psychiatry. 1995 Sep;152(9):1368-71. doi: 10.1176/ajp.152.9.1368. Am J Psychiatry. 1995. PMID: 7653696 Clinical Trial.

10

Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.

Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC. Greist JH, et al. Among authors: kobak ka. Arch Gen Psychiatry. 1995 Jan;52(1):53-60. doi: 10.1001/archpsyc.1995.03950130053006. Arch Gen Psychiatry. 1995. PMID: 7811162

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters